[PDF] Prospectus - Dr. Martens plc 29 gen 2021 attached prospectus (





Previous PDF Next PDF



Dr. Martens plc FY21 results presentation

17 giu 2021 INTRODUCTION TO DR. MARTENS. Iconic brand and iconic product. Broad appeal. Consumers love their Docs. Direct to consumer led model.



DR. MARTENS PLC ANNUAL REPORT 2022

31 mag 2022 The first boot was born on 1 April 1960 in Wollaston England



Prospectus - Dr. Martens plc

29 gen 2021 attached prospectus (the "Prospectus") relating to Dr. Martens plc (the "Company") dated 29 January 2021 accessed from this page or.



Dr. Martens plc Annual Report 2021

27 lug 2021 Annual Report 2021 Dr. Martens plc. WHAT WE DO. Dr. Martens is an iconic global brand and one of the most recognised footwear brands in the ...



Dr. Martens plc Sustainability Report

Creating a fairer and more sustainable world is a challenge. But if there's one thing. Dr. Martens is good at it's being brave and standing up for what.



FY22 results presentation

1 giu 2022 Dr. Martens brand is stronger than ever. Confident in year ahead and continued delivery of strategy. Page 4. Page 5. AGENDA.



FIRST HALF RESULTS FY22

9 dic 2021 THIS IS WHERE DR. MARTENS IS HEADING. THIS IS WHAT WE'RE WORKING TOWARDS ... Barnes@drmartens.com. Mobile: +44 7825 187465. Sunena Dhuna.



AND TRANSPARENCY IN THE SUPPLY CHAIN STATEMENT

This statement covers Dr. Martens plc and other group companies and is made pursuant to section 54 of the Modern Slavery Act 2015 and California Transparency in 



Dr. Martens plc FY21 results statement

17 giu 2021 Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking.



Dr. Martens Modern Slavery and transparency in the supply chain

This statement covers Dr. Martens Airwair Group Ltd. and other group companies. This statement is made pursuant to Section 54 of the Modern Slavery Act 2015 and 



What is Dr Martens?

What is Dr. Martens? Docs will forever remain the coolest thing in your closet—even after you've worn them down to their soles. Dr. Martens, commonly d? "Doc Martens" or "Docs," may initially evoke images of 6-inch goth-looking combat boots, but its beginnings are a little more humble.

How versatile is Dr Martens 2976?

The outer sole and heel area, usually wooden on most boots, has the signature Dr. Martens rubber with grooved sides that looks sleek. How Versatile is Dr. Martens 2976? These boots are very versatile. You can wear and pair them with just about anything, which is why I got them.

Are Dr Martens good boots?

– Review Dr. Martens boots are the most common boots I’ve seen worn. You can spot a person wearing docs by the heel tag or famous yellow stitching on the soles. There has been this hype over them for years that I never quite understood. A few months ago, I needed a comfortable pair of versatile boots, one I can easily slip on and slip off.

Does Dr Martens kick against the norm?

Whatever you call them (Doc Martens, Docs, DMs), one thing’s for certain: Dr. Martens kicks against the norm.

ELECTRONIC TRANSMISSION DISCLAIMER

STRICTLY NOT TO BE FORWARDED TO ANY OTHER PERSONS

IMPORTANT: You must read the following disclaimer before continuing. This electronic transmission applies to the attached

Prospectus and you are therefore advised to read this disclaimer carefully before reading, accessing or making any other use of the

attached prospectus (the "Prospectus") relating to Dr. Martens plc (the "Company") dated 29 January 2021 accessed from this page or

otherwise received as a result of such access and you are therefore advised to read this disclaimer carefully before reading, accessing

or making any other use of the attached Prospectus. In accessing the attached Prospectus, you agree to be bound by the following

terms and conditions, including any modifications to them from time to time, each time you receive any information from us as a

result of such access. You acknowledge that this electronic transmission and the delivery of the attached Prospectus is confidential

and intended for you only and you agree you will not forward, reproduce or publish this electronic transmission or the attached

Prospectus to any other person. The Prospectus has been prepared solely in connection with the proposed offer to certain institutional

investors (the "Offer") of ordinary shares (the "Shares") of the Company. The Prospectus has been published in connection with the

admission of the Shares to the premium listing segment of the Official List of the UK Financial Conduct Authority (the "FCA") and

to trading on London Stock Exchange plc's main market for listed securities (together, "Admission"). The Prospectus has been

approved by the FCA as a prospectus prepared in accordance with the Prospectus Regulation Rules made under section 73A of the

Financial Services and Markets Act 2000. The Prospectus is available on the Company's website at www.drmartensplc.com. Pricing

information and other related disclosures are expected to be published on this website. Prospective investors are advised to access

such information prior to making an investment decision. THIS ELECTRONIC TRANSMISSION AND THE ATTACHED PROSPECTUS MAY ONLY BE DISTRIBUTED IN "OFFSHORE TRANSACTIONS" AS DEFINED IN, AND IN RELIANCE ON, REGULATION S UNDER THE US SECURITIES

ACT OF 1933, AS AMENDED (THE "US SECURITIES ACT") OR WITHIN THE UNITED STATES TO PERSONS

REASONABLY BELIEVED TO BE QUALIFIED INSTITUTIONAL BUYERS ("QIBs") AS DEFINED IN RULE 144A UNDER THE US SECURITIES ACT ("RULE 144A") OR ANOTHER EXEMPTION FROM, OR TRANSACTION NOT SUBJECT TO, REGISTRATION UNDER THE US SECURITIES ACT. ANY FORWARDING, DISTRIBUTION OR REPRODUCTION OF THE ATTACHED PROSPECTUS IN WHOLE OR IN PART IS UNAUTHORISED. FAILURE TO COMPLY WITH THIS NOTICE MAY RESULT IN A VIOLATION OF THE US SECURITIES ACT OR THE APPLICABLE LAWS OF OTHER JURISDICTIONS. NOTHING IN THIS ELECTRONIC TRANSMISSION AND THE ATTACHED PROSPECTUS CONSTITUTES AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DO SO. THE SECURITIES HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE US SECURITIES ACT OR WITH ANY SECURITIES REGULATORY AUTHORITY OF ANY STATE OF THE UNITED STATES OR OTHER JURISDICTION AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (1) TO A PERSON THAT THE HOLDER AND ANY PERSON ACTING ON ITS BEHALF REASONABLY BELIEVES IS A QIB AS DEFINED IN, OR IN RELIANCE ON, RULE 144A, OR ANOTHER EXEMPTION FROM, OR TRANSACTION NOT SUBJECT TO, THE

REGISTRATION REQUIREMENTS OF THE US SECURITIES ACT, OR (2) IN AN OFFSHORE TRANSACTION IN

ACCORDANCE WITH RULE 903 OR RULE 904 OF REGULATION S UNDER THE US SECURITIES ACT, IN EACH CASE IN ACCORDANCE WITH ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES. CANADIAN INVESTORS ARE ADVISED THAT THIS EMAIL AND THE PROSPECTUS ATTACHED HERETO MAY ONLY BE TRANSMITTED IN THOSE JURISDICTIONS IN CANADA AND TO THOSE PERSONS WHERE AND TO WHOM THEY MAY BE LAWFULLY OFFERED FOR SALE AND THEREIN ONLY BY PERSONS PERMITTED TO SELL SUCH SECURITIES. THE PROSPECTUS ATTACHED HERETO IS NOT AND UNDER NO CIRCUMSTANCES IS TO BE CONSTRUED AS, AN ADVERTISEMENT OR A PUBLIC OFFERING IN CANADA. NO SECURITIES COMMISSION OR SIMILAR AUTHORITY IN CANADA HAS REVIEWED OR IN ANY WAY PASSED UPON THE PROSPECTUS ATTACHED HERETO OR THE MERITS OF THE SECURITIES DESCRIBED THEREIN AND ANY REPRESENTATION TO THE CONTRARY IS AN OFFENCE. THE DISTRIBUTION OF THE SECURITIES CONTAINED IN THE PROSPECTUS

ATTACHED HERETO IS BEING MADE ON A PRIVATE PLACEMENT BASIS ONLY AND IS EXEMPT FROM THE

REQUIREMENT THAT THE COMPANY PREPARE AND FILE A PROSPECTUS WITH THE RELEVANT CANADIAN

SECURITIES REGULATORY AUTHORITIES.

ANY FORWARDING, REDISTRIBUTION OR REPRODUCTION OF THE PROSPECTUS IN WHOLE OR IN PART IS

UNAUTHORISED. FAILURE TO COMPLY WITH THIS DIRECTIVE MAY RESULT IN A VIOLATION OF THE US

SECURITIES ACT OR THE APPLICABLE LAWS OF OTHER JURISDICTIONS.

This electronic transmission and the attached Prospectus and the Offer when made are only addressed to and directed at persons in

member states of the European Economic Area who are "qualified investors" within the meaning of Article 2(e) of Regulation (EU)

2017/1129 (the "Prospectus Regulation") ("Qualified Investors"). In the United Kingdom, this electronic transmission and the

attached Prospectus is being distributed only to, and is directed only at, persons: (A) (i) who have professional experience in matters

relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order

2005, as amended (the "Order"), (ii) falling within Article 49(2)(a) to (d) of the Order and (iii) to whom it may otherwise lawfully be

communicated; and (B) who are "qualified investors" within the meaning of Article 2(e) of the Prospectus Regulation (Regulation

(EU) 2017/1129) as it forms part of retained EU law as defined in the European Union (Withdrawal) Act 2018 (all such persons

together being referred to as "relevant persons"). This electronic transmission and the attached Prospectus must not be acted on or

relied on (i) in the United Kingdom, by persons who are not relevant persons, and (ii) in any member state of the European Economic

Area, by persons who are not Qualified Investors. Any investment or investment activity to which the attached Prospectus relates is

available only to (i) in the United Kingdom, relevant persons, and (ii) in any member state of the European Economic Area, Qualified

Investors, and will be engaged in only with such persons.

Confirmation of Your Representation: This electronic transmission and the attached Prospectus is delivered to you on the basis

that you are deemed to have represented to the Company and Morgan Stanley & Co. International plc (the "Sponsor"), Goldman

Sachs International, (with Morgan Stanley & Co. International plc, the "Joint Global Co-ordinators"), Barclays Bank PLC, HSBC

Bank plc, Merrill Lynch International and RBC Europe Limited (along with the Joint Global Co-ordinators, the "Joint Bookrunners"),

Banco Santander, S.A. and Raiffeisen Bank International AG (the "Co-lead Managers", and along with the Joint Bookrunners, the

"Underwriters"), that (i) you are (a) a QIB acquiring such securities for its own account or for the account of another QIB or (b)

acquiring such securities in "offshore transactions", as defined in, and in reliance on, Regulation S under the US Securities Act; (ii) if

you are in the United Kingdom, you are a relevant person and/or a relevant person who is acting on behalf of relevant persons in the

United Kingdom to the extent you are acting on behalf of persons or entities in the United Kingdom; (iii) if you are in any member

state of the European Economic Area, you are a Qualified Investor and/or a Qualified Investor acting on behalf of Qualified Investors

to the extent you are acting on behalf of persons or entities in the European Economic Area; (iv) the securities acquired by you in the

offer have not been acquired on a non-discretionary basis on behalf of, nor have they been acquired with a view to their offer or

resale to, any person in circumstances which may constitute or give rise to an offer of any securities to the public other than their

offer or resale, in the United Kingdom. to relevant persons, and in any member state of the European Economic Area, to Qualified

Investors; (v) if you are outside the United States, United Kingdom and European Economic Area (and the electronic mail address

that you provided and to which this Prospectus has been delivered are not located in such jurisdictions) you are a person into whose

possession this Prospectus may lawfully be delivered in accordance with the laws of the jurisdiction in which you are located; and

(vi) you are an institutional investor that is eligible to receive the attached Prospectus and you consent to delivery by electronic

transmission.

For investors resident in British Columbia, Alberta, Manitoba, Ontario and Quebec (the "Relevant Provinces"). You acknowledge and

agree that (a) the securities described in the attached Prospectus are only being distributed to investors resident in the Relevant

Provinces, (b) you are (i) an "accredited investor" as such term is defined in National Instrument 45-106 Prospectus Exemptions and

(ii) a "permitted client", as such term is defined in National Instrument 31-101 Registration Requirements. Exemptions and Ongoing

Registrant Obligations(NI 31-103) and are purchasing the Shares from a dealer registered in Canada or relying on the "international

dealer exemption" contained in NI 31-103; and (c) where required by law, you are participating in the offering as principal for your

own account and not as agent.

You are reminded that you have received this electronic transmission and the attached Prospectus on the basis that you are a person

into whose possession the attached Prospectus may be lawfully delivered in accordance with the laws of the jurisdiction in which you

are located and you may not nor are you authorised to deliver the attached Prospectus, electronically or otherwise, to any other

person. The attached Prospectus has been made available to you in an electronic form. You are reminded that Prospectus transmitted

via this medium may be altered or changed during the process of electronic transmission and consequently neither the Company, the

Underwriters, the Financial Adviser nor any of their respective affiliates accepts any liability or responsibility whatsoever in respect

of any difference between the Prospectus distributed to you in electronic format and the hard copy version. A hard copy of the

Prospectus will be made available to you only upon request.

By accessing the linked Prospectus, you consent to receiving it in electronic form. None of the Underwriters, the Financial Adviser

nor any of their respective affiliates accepts any responsibility whatsoever for the contents of the attached Prospectus or for any

statement made or purported to be made by it, or on its behalf, in connection with the Company or the Shares. The Underwriters, the

Financial Adviser and each of their respective affiliates, each accordingly disclaims all and any liability whether arising in tort,

contract or otherwise which they might otherwise have in respect of such Prospectus or any such statement. No representation or

warranty express or implied, is made by any of the Underwriters or any of their respective affiliates as to the accuracy, completeness,

verification or sufficiency of the information set out in the attached Prospectus.

The Underwriters and the Financial Adviser are acting exclusively for the Company and no one else in connection with the Offer.

They will not regard any other person (whether or not a recipient of the attached Prospectus) as their client in relation to the Offer and

will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients nor for

giving advice in relation to the Offer or any transaction or arrangement referred to in the attached Prospectus.

Restriction: Nothing in this electronic transmission constitutes, and this electronic transmission may not be used in connection with,

an offer of securities for sale to persons other than the specified categories of institutional buyers described above and to whom it is

directed and access has been limited so that it shall not constitute a general solicitation. If you have gained access to this transmission

contrary to the foregoing restrictions, you will be unable to purchase any of the securities described therein.

You are responsible for protecting against viruses and other destructive items. Your receipt of this Prospectus via electronic

transmission is at your own risk and it is your responsibility to take precautions to ensure that it is free from viruses and other items

of a destructive nature.

6800$5<

QXPEHULQJVHTXHQFHRIWKH(OHPHQWV

$'DWHRIDSSURYDORIWKHSURVSHFWXV $:DUQLQJ

6(&7,21%².(<,1)250$7,21217+(,668(5

%:KRLVWKHLVVXHURIWKHVHFXULWLHV" %3ULQFLSDODFWLYLWLHV %0DMRUVKDUHKROGHUV ,PPHGLDWHO\

SULRUWR

$GPLVVLRQ1XPEHURI

6KDUHVWREH

VROGLQWKH2IIHU,PPHGLDWHO\

IROORZLQJ

$GPLVVLRQ6KDUHKROGHUV1XPEHU

RI6KDUHV3HUFHQWDJH

RILVVXHG

VKDUH

FDSLWDO1XPEHU

RI6KDUHV3HUFHQWDJH

RILVVXHG

VKDUH

FDSLWDO1XPEHU

RI6KDUHV3HUFHQWDJH

RILVVXHG

VKDUH

FDSLWDO

SDULSDVVX

%.H\PDQDJLQJGLUHFWRUV %,GHQWLW\RIWKHVWDWXWRU\DXGLWRUV +LVWRULFDO)LQDQFLDO,QIRUPDWLRQ

6HOHFWHGILQDQFLDOLQIRUPDWLRQ

...P

XQDXGLWHG5HYHQXH

*URVVSURILW

2SHUDWLQJSURILW

(%,7'$ (%,7'$SRVWH[FHSWLRQDOLWHPV

2SHUDWLQJSURILW

3URILWEHIRUHLQFRPHWD[

3URILWORVVIRUWKHSHULRG\HDU

DWWULEXWDEOHWRWKHRZQHUVRIWKHSDUHQW

5HFRQFLOLDWLRQRI(%,7'$WR(%,7'$

SUHVHQWHGRQDQ,$6EDVLV

(%,7'$ ...P1RQFXUUHQWDVVHWV &XUUHQWDVVHWV

7RWDODVVHWV

$VDW0DUFK$VDW6HSWHPEHU ...P&XUUHQWOLDELOLWLHV

1RQFXUUHQWOLDELOLWLHV

7RWDOOLDELOLWLHV

1HWDVVHWVOLDELOLWLHV

(TXLW\DWWULEXWDEOHWRRZQHUVRIWKHSDUHQW ...P

XQDXGLWHG

6HSWHPEHU

...P

XQDXGLWHG

2SHUDWLQJFDVKIORZ

)UHHFDVKIORZ &ORVLQJFDVK

3URIRUPDILQDQFLDOLQIRUPDWLRQ

*URXS

QHWDVVHWVDW

GRZQXQGHUWKH1HZ

IRUPDQHWDVVHWVDW

&XUUHQWDVVHWV

7RWDODVVHWV

&XUUHQWOLDELOLWLHV

1RQFXUUHQWOLDELOLWLHV

7RWDOOLDELOLWLHV

1HWDVVHWV²²

+LVWRULFDO)LQDQFLDO,QIRUPDWLRQ

5HRUJDQLVDWLRQ$GGLWLRQDO,QIRUPDWLRQ

&:KDWDUHWKHPDLQIHDWXUHVRIWKHVHFXULWLHV" &7\SHFODVVDQG,6,1 &5LJKWVDWWDFKLQJWRWKH6KDUHV &5HVWULFWLRQVRQWUDQVIHU &'LYLGHQGRUSD\RXWSROLF\ &:KHUHZLOOWKHVHFXULWLHVEHWUDGHG" $'0,66,217275$',1*21$5(*8/$7('0$5.(7 ':K\LVWKLVSURVSHFWXVEHLQJSURGXFHG" 3DUW

5LVN)DFWRUV

XQFHUWDLQWLHVGHVFULEHGEHORZ

3URVSHFWXVDQGWKHLUSHUVRQDOFLUFXPVWDQFHV

3URVSHFWXV

FRXOGEHDGYHUVHO\DIIHFWHG

7KH&29,'SDQGHPLFKDVDIIHFWHGDQG

DQGSURVSHFWV5LVN)DFWRUV

)DFWRUV ,IWKH*URXSHQFRXQWHUV ,IWKH*URXSLVXQDEOH

5LVN)DFWRUV

PD\EHKDUPHG

5LVN)DFWRUV

HIILFLHQF\LQLWLDWLYHVLWXQGHUWDNHV

EXVLQHVVFRXOGEHDGYHUVHO\DIIHFWHG

LWVEXVLQHVV

RISRWHQWLDORSHUDWLRQDOULVNV

5LVNVUHODWLQJWRFRPSOLDQFHDQGUHJXODWLRQ

UHSXWDWLRQDQGH[SRVHLWWROLWLJDWLRQ

'U0DUWHQVEUDQG5LVN)DFWRUV

HQYLURQPHQWDODQGRWKHUODZVDQGUHJXODWLRQV

5LVNVUHODWLQJWRWKH2IIHUDQGWKH6KDUHV

5LVN)DFWRUV

GHYHORSRUEHVXVWDLQHG

WKDWWKHVHVDOHVFRXOGRFFXU

DEOHWRSDUWLFLSDWHLQIXWXUHHTXLW\RIIHULQJV

RWKHU6KDUHKROGHUV

3$57 *HQHUDO

2YHUDOORWPHQWDQGVWDELOLVDWLRQ

SDULSDVVX

3UHVHQWDWLRQRIILQDQFLDOLQIRUPDWLRQ

,QIRUPDWLRQ )LQDQFLDOLQIRUPDWLRQ +LVWRULFDO)LQDQFLDO ,QIRUPDWLRQ +LVWRULFDO)LQDQFLDO,QIRUPDWLRQ +LVWRULFDO)LQDQFLDO ,QIRUPDWLRQ +LVWRULFDO)LQDQFLDO,QIRUPDWLRQ +LVWRULFDO)LQDQFLDO ,QIRUPDWLRQ

3URIRUPDILQDQFLDOLQIRUPDWLRQ

8QDXGLWHG3UR)RUPD)LQDQFLDO,QIRUPDWLRQ

8QDXGLWHG3UR)RUPD)LQDQFLDO,QIRUPDWLRQ

1RQ,)56ILQDQFLDOLQIRUPDWLRQ

XQDXGLWHG (%,7'$ (%,7'$SUH,)56 (%,7'$PDUJLQXQDXGLWHG (%,7'$SUH,)56PDUJLQXQDXGLWHG XQDXGLWHG

2SHUDWLQJFDVKIORZ

2SHUDWLQJFDVKIORZFRQYHUVLRQXQDXGLWHG

/LNHIRUOLNHJURZWKquotesdbs_dbs22.pdfusesText_28
[PDF] activité cohésion équipe

[PDF] activité brise glace réunion déquipe

[PDF] jeu pour faire connaissance groupe adulte

[PDF] expérience énergie cycle 3

[PDF] activité petite enfance crèche

[PDF] activité manuelle petite enfance

[PDF] activité pour tout petit 0 3 ans

[PDF] idees activites en creche

[PDF] activité d'éveil en crèche

[PDF] les activités déveil des tout petit fleurus

[PDF] jeux mathématiques nombres relatifs

[PDF] addition de relatifs exercices

[PDF] activité addition nombres relatifs 5ème

[PDF] exercices somme de relatifs

[PDF] soustraction relatifs 5ème